Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
BMC Infectious Diseases|April 14, 2023
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimensPaolo Maggi, Elena Delfina Ricci, Stefania Cicalini, et al.
AIDS (London, England)|March 17, 2023
Incident diabetes in course of antiretroviral therapyLucia Taramasso, Nicola Squillace, Elena Ricci, et al.
Plos One|August 9, 2023
Real-life safety of Emtricitabine/Tenofovir Alafenamide/BictegravirNicola Squillace, Elena Ricci, Paolo Maggi, et al.
The Patient|May 30, 2020
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral SuppressionAndrea Antinori, Maria V Cossu, Barbara Menzaghi, et al.
The Patient|April 9, 2020
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral SuppressionAndrea Antinori, Maria V Cossu, Barbara Menzaghi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2020
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" StudyAndrea Gori, Andrea Antinori, Alessandra Vergori, et al.
BMC Infectious Diseases|September 23, 2022
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?Paolo Maggi, Giuseppe Vittorio De Socio, Barbara Menzaghi, et al.
Open Forum Infectious Diseases|June 25, 2020
Factors Associated With Weight Gain in People Treated With DolutegravirLucia Taramasso, Paolo Bonfanti, Elena Ricci, et al.
AIDS Research and Treatment|October 6, 2025
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple RegimenPaolo Maggi, Addolorata Masiello, Barbara Menzaghi, et al.
AIDS Patient Care and Stds|September 15, 2021
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational StudyLucia Taramasso, Andrea De Vito, Elena Delfina Ricci, et al.
Pageof 7